Cargando…

Serum total hCGβ level is an independent prognostic factor in transitional cell carcinoma of the urothelial tract

BACKGROUND: Serum total human chorionic gonadotrophin β subunit (hCGβ) level might have prognostic value in urothelial transitional cell carcinoma (TCC) but has not been investigated for independence from other prognostic variables. METHODS: We utilised a clinical database of patients receiving chem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Douglas, J, Sharp, A, Chau, C, Head, J, Drake, T, Wheater, M, Geldart, T, Mead, G, Crabb, S J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974095/ https://www.ncbi.nlm.nih.gov/pubmed/24556622 http://dx.doi.org/10.1038/bjc.2014.89

Ejemplares similares

External validation of serum hCG cutoff levels for prediction of resistance to single-agent chemotherapy in patients with persistent trophoblastic disease
por: Kerkmeijer, L G, et al.
Publicado: (2009)

Early prediction of treatment resistance in low-risk gestational trophoblastic neoplasia using population kinetic modelling of hCG measurements
por: You, B, et al.
Publicado: (2013)

Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer
por: Boman, K, et al.
Publicado: (2013)

Biological functions of hCG and hCG-related molecules
por: Cole, Laurence A
Publicado: (2010)

Expression of parvin-β is a prognostic factor for patients with urothelial cell carcinoma of the upper urinary tract
por: Wu, C-F, et al.
Publicado: (2010)

Validation of the pretreatment derived neutrophil–lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma
por: Dalpiaz, O, et al.
Publicado: (2014)

Different hCG assays to measure ectopic hCG secretion in bladder carcinoma patients.
por: Mora, J., et al.
Publicado: (1996)

Validation of (125)I-hCG as a marker for elimination of hCG and stability of (125)I-hCG after in vivo injection in humans
por: Christensen, T B, et al.
Publicado: (1999)

Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinoma
por: Wallard, M J, et al.
Publicado: (2006)

Combined proteome and transcriptome analyses for the discovery of urinary biomarkers for urothelial carcinoma
por: Shimwell, N J, et al.
Publicado: (2013)

Urothelial carcinoma of the prostate with raised β-hCG levels: a case report
por: Sołek, Julia, et al.
Publicado: (2022)

Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential
por: Bryan, R T, et al.
Publicado: (2014)

MT1-MMP regulates urothelial cell invasion via transcriptional regulation of Dickkopf-3
por: Saeb-Parsy, K, et al.
Publicado: (2008)

Protein shedding in urothelial bladder cancer: prognostic implications of soluble urinary EGFR and EpCAM
por: Bryan, R T, et al.
Publicado: (2015)

Tumour-initiating capacity is independent of epithelial–mesenchymal transition status in breast cancer cell lines
por: Xie, G, et al.
Publicado: (2014)

Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted
por: Langbein, S, et al.
Publicado: (2006)

hCG, the wonder of today's science
por: Cole, Laurence A
Publicado: (2012)

A urinary microRNA signature can predict the presence of bladder urothelial carcinoma in patients undergoing surveillance
por: Sapre, Nikhil, et al.
Publicado: (2016)

MicroRNA promoter methylation: a new tool for accurate detection of urothelial carcinoma
por: Padrão, Nuno André, et al.
Publicado: (2017)

Expression of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinoma
por: Dyrskjøt, L, et al.
Publicado: (2012)

Prognostic significance of Bcl-xL expression and efficacy of Bcl-xL targeting therapy in urothelial carcinoma
por: Yoshimine, S, et al.
Publicado: (2013)

Met expression is an independent prognostic risk factor in patients with oesophageal adenocarcinoma
por: Tuynman, J B, et al.
Publicado: (2008)

Beta-hCG expression by bladder cancers.
por: Iles, R.
Publicado: (1992)

hCG: Biological Functions and Clinical Applications
por: Nwabuobi, Chinedu, et al.
Publicado: (2017)

hCG Triggering in ART: An Evolutionary Concept
por: Hershko Klement, Anat, et al.
Publicado: (2017)

p53 and cell cycle independent dysregulation of autophagy in chronic lymphocytic leukaemia
por: Groves, M J, et al.
Publicado: (2013)

Determinants of the hCG Concentration in the Early Luteal Phase After Final Maturation of Follicles With Bolus Trigger of Recombinant hCG
por: Vuong, Lan N., et al.
Publicado: (2020)

Disabled-2 downregulation promotes epithelial-to-mesenchymal transition
por: Martin, J C, et al.
Publicado: (2010)

CD133 expression is an independent prognostic marker for low survival in colorectal cancer
por: Horst, D, et al.
Publicado: (2008)

The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer
por: Popple, A, et al.
Publicado: (2012)

The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients
por: West, N P, et al.
Publicado: (2010)

(125)I-labelled human chorionic gonadotrophin (hCG) as an elimination marker in the evaluation of hCG decline during chemotherapy in patients with testicular cancer
por: Christensen, T B, et al.
Publicado: (1999)

Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients
por: Hinnis, A R, et al.
Publicado: (2007)

Nuclear survivin expression is associated with HPV-independent carcinogenesis and is an indicator of poor prognosis in oropharyngeal cancer
por: Preuss, S F, et al.
Publicado: (2008)

High CIP2A immunoreactivity is an independent prognostic indicator in early-stage tongue cancer
por: Böckelman, C, et al.
Publicado: (2011)

TGFBI expression is an independent predictor of survival in adjuvant-treated lung squamous cell carcinoma patients
por: Pajares, M J, et al.
Publicado: (2014)

Comparison of hCG triggering versus hCG in combination with a GnRH agonist: a prospective randomized controlled trial
por: Decleer, W., et al.
Publicado: (2014)

ALDH1 is an independent prognostic factor for patients with stages II–III rectal cancer after receiving radiochemotherapy
por: Deng, Y, et al.
Publicado: (2014)

Independent and functional validation of a multi-tumour-type proliferation signature
por: Starmans, M H W, et al.
Publicado: (2012)

TBLR1 is a novel prognostic marker and promotes epithelial–mesenchymal transition in cervical cancer
por: Wang, J, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ca0hn27p5qsd48kdp4r0ummqvv